Dr. Markman on Potential Neuropathy Biomarkers

Video

In Partnership With:

Dr. Markman on Taxane-Induced Neuropathy Biomarkers

Maurie Markman, MD the National Director for Medical Oncology for the Cancer Treatment Centers of America on Taxane-Induced Neuropathy Biomarkers

Related Videos
Sundar Jagannath, MBBS
Elias Jabbour, MD
Rebecca Klisovic, MD
Axel Hauschild, MD, PhD, head, Skin Cancer Trial Center, University Hospital Schleswig-Holstein
David L. Porter, MD, director, Cell Therapy and Transplant, Jodi Fisher Horowitz Professor in Leukemia Care Excellence, Penn Medicine
Jubilee Brown, MD
Changchun Deng, MD, PhD
Laura J. Chambers, DO
Casey M. Cosgrove, MD
Vaidehi Mujumdar, MD
Related Content
Maurie Markman, MD

Improved Survival in Randomized Trials: A Meaningful Outcome but Increasingly Difficult to Demonstrate

May 9th 2024
Article
Matthew Lunning, DO, FACP, associate professor, the Division of Oncology & Hematology, associate vice chair, research, the Department of Internal Medicine, assistant vice chancellor, clinical research, the University of Nebraska Medical Center

Lunning and Herrera Highlight Frontline Hodgkin Lymphoma Management Strategies

March 18th 2024
Podcast
Ibrahim Aldoss, MD, of City of Hope

MRD-Negative CR Separates Ponatinib From the Rest in Newly Diagnosed, Ph+ ALL

April 15th 2024
Article
Diane M. Simeone, MD; Marwan G. Fakih, MD

Simeone and Fakih Detail Research Objectives With A2B530 in CEA-Expressing Solid Tumors

December 18th 2023
Podcast
Richard T. Lee, MD, of City of Hope

The New Frontier With Integrative Oncology: Shooting for the Stars

April 11th 2024
Article
doctor-adobe.stock

A Medical Oncologist’s Insights on Cannabis Use in the Care of Patients With Hematologic Malignancies

April 2nd 2024
Article